Clinical experience with survivin as a biomarker for urothelial bladder cancer-Reference-Cited by-同舟云学术

Clinical experience with survivin as a biomarker for urothelial bladder cancer

Published:2010-03-23 Issue:3 Volume:28 Page:399-404
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Horstmann Marcus,Bontrup Heike,Hennenlotter Jörg,Taeger Dirk,Weber Anne,Pesch Beate,Feil Gerhard,Patschan Oliver,Johnen Georg,Stenzl Arnulf,Brüning Thomas

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-010-0538-2.pdf

Reference19 articles.

1. Barocas DA, Clark PE (2008) Bladder cancer. Curr Opin Oncol 20:307–314

2. Noyes K, Singer EA, Messing EM (2008) Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors. Curr Opin Urol 18:533–539

3. Stenzl A, Hennenlotter J, Schilling D (2008) Can we still afford bladder cancer? Curr Opin Urol 18:488–492

4. Vrooman OP, Witjes JA (2008) Urinary markers in bladder cancer. Eur Urol 53:909–916

5. Lokeshwar VB, Selzer MG (2006) Urinary bladder tumor markers. Urol Oncol 24:528–537

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivin as a potential biomarker in the diagnosis of bladder cancer: A systematic review and meta-analysis;Urologic Oncology: Seminars and Original Investigations;2024-05

2. Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non–muscle-Invasive Bladder Cancer;Urologic Clinics of North America;2023-02

3. Urothelkarzinom der Harnblase: Diagnostik;Die Urologie;2023

4. Application of synthetic biology in bladder cancer;Chinese Medical Journal;2022-09-20

5. Urothelkarzinom der Harnblase: Diagnostik;Die Urologie;2022